logo
  

Teva Pharmaceutical Industries Limited Q3 adjusted earnings Miss Estimates

Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):

-Earnings: $0.29 billion in Q3 vs. -$4.35 billion in the same period last year.
-EPS: $0.26 in Q3 vs. -$3.97 in the same period last year.
-Excluding items, Teva Pharmaceutical Industries Limited reported adjusted earnings of $651 million or $0.59 per share for the period.
-Analysts projected $0.65 per share
-Revenue: $3.89 billion in Q3 vs. $3.98 billion in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT